European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval #European #Union #fines #biotech #giant #Illumina #million #cancerscreening #company #Grail #approval

European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval

BRUSSELS — European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval.

#European #Union #fines #biotech #giant #Illumina #million #cancerscreening #company #Grail #approval

Leave a Reply

Your email address will not be published. Required fields are marked *